Have a feature idea you'd love to see implemented?
Let us know!
AWH Aspira Women's Health Inc
Price (delayed)
$0.7478
Market cap
$12.46M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.17
Enterprise value
$12.47M
Aspira Women's Health Inc. operates as a biotech company. The Company develops and discovers testing and treatments for gynecologic issues. Aspira Women's Health serves customers in the State of Texas.
Highlights
The EPS has grown by 43% YoY and by 18% from the previous quarter
The company's equity rose by 32% QoQ
The company's quick ratio has shrunk by 54% YoY but it rose by 41% QoQ
Aspira Women's Health's revenue has decreased by 2.3% YoY
Key stats
What are the main financial stats of AWH
Market
Valuations
Earnings
Shares outstanding
16.67M
Market cap
$12.46M
Enterprise value
$12.47M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.39
Revenue
$8.96M
EBIT
-$14.78M
EBITDA
-$14.66M
Free cash flow
-$14.59M
Per share
Balance sheet
Liquidity
EPS
-$1.17
Free cash flow per share
-$0.95
Book value per share
-$0.16
Revenue per share
$0.58
TBVPS
$0.31
Total assets
$4.76M
Total liabilities
$7.28M
Debt
$2.14M
Equity
-$2.52M
Working capital
-$1.35M
Debt to equity
-0.85
Current ratio
0.75
Quick ratio
0.62
Net debt/EBITDA
0
Margins
Efficiency
Dividend
EBITDA margin
-163.6%
Gross margin
58.1%
Net margin
-165.1%
Operating margin
-189.5%
Return on assets
-267.2%
Return on equity
N/A
Return on invested capital
-4,812.7%
Return on capital employed
N/A
Return on sales
-164.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AWH stock price
How has the Aspira Women's Health stock price performed over time
Intraday
2.44%
1 week
1.04%
1 month
-14.05%
1 year
-75.72%
YTD
-81.67%
QTD
-7.68%
Financial performance
How have Aspira Women's Health's revenue and profit performed over time
Revenue
$8.96M
Gross profit
$5.21M
Operating income
-$16.98M
Net income
-$14.8M
Gross margin
58.1%
Net margin
-165.1%
The net income has grown by 19% year-on-year and by 7% since the previous quarter
The net margin has increased by 17% year-on-year and by 8% since the previous quarter
The operating income has grown by 14% year-on-year and by 2.1% since the previous quarter
Aspira Women's Health's operating margin has increased by 12% YoY and by 2.6% from the previous quarter
Growth
What is Aspira Women's Health's growth rate over time
Valuation
What is Aspira Women's Health stock price valuation
P/E
N/A
P/B
N/A
P/S
1.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.39
The EPS has grown by 43% YoY and by 18% from the previous quarter
The company's equity rose by 32% QoQ
AWH's price to sales (P/S) is 96% less than its 5-year quarterly average of 36.6 and 56% less than its last 4 quarters average of 2.9
Aspira Women's Health's revenue has decreased by 2.3% YoY
Efficiency
How efficient is Aspira Women's Health business performance
Aspira Women's Health's ROIC has plunged by 169% YoY and by 82% from the previous quarter
The ROA has plunged by 66% YoY and by 9% from the previous quarter
The ROS has grown by 17% YoY and by 8% from the previous quarter
Dividends
What is AWH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AWH.
Financial health
How did Aspira Women's Health financials performed over time
Aspira Women's Health's total assets is 35% less than its total liabilities
The company's quick ratio has shrunk by 54% YoY but it rose by 41% QoQ
The company's current ratio fell by 49% YoY but it rose by 25% QoQ
The debt is 185% greater than the equity
Aspira Women's Health's debt to equity has soared by 76% YoY but it has decreased by 33% from the previous quarter
The company's equity rose by 32% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.